Higby, K., Xenakis, E. M., & Pauerstein, C. J. (1993). Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. American Journal of Obstetrics and Gynecology, 168(4), 1247-1259. https://doi.org/10.1016/0002-9378(93)90376-t
Higby K, Xenakis EM, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol. 1993;168(4):1247-1259. doi:10.1016/0002-9378(93)90376-t
Higby, Kenneth, et al. "Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety." American Journal of Obstetrics and Gynecology, vol. 168, no. 4, 1993, pp. 1247-1259.
For EndNote, Zotero or Mendeley:
License
Open-access status not yet checked.
Author affiliations
1 institution
The University of Texas Health Science Center at San Antonio02f6dcw23
Linked to ROR, the Research Organization Registry
RRM Academy Synopsis
Only prostaglandin inhibitors might stop preterm labor, 1993 review
A 1993 review of 328 studies concluded that prostaglandin inhibitors were the only drugs that might stop preterm labor. Magnesium sulfate performed no better than placebo, and beta-adrenergic receptor agonists delayed labor for just 24 to 48 hours.
Key Findings
Prostaglandin inhibitors seemed effective and produced few adverse side effects.
Beta-adrenergic receptor agonists halted labor for only 24 to 48 hours.
Calcium channel blockers and oxytocin antagonists reduced uterine contractions, yet whether they actually stop labor remains undefined.
Across randomized trials with a placebo group, magnesium sulfate gave results no better than placebo.
The review drew on 328 studies, published from 1933 through 1992, of drugs given for premature labor.
Interpretation
The authors reviewed published studies from 1933 through 1992 and drew a conclusion for each drug class. This summary rests on the published abstract alone, which gives a narrative judgment and no pooled effect sizes. The conclusions are worded with care: prostaglandin inhibitors "might be effective," and the authors limit tocolytic drugs to 24 to 32 completed weeks of gestation. The review dates from 1993 and addresses the drugs available then.
RRM Context
Preterm birth is a leading source of newborn illness, and drugs that postpone labor by 48 hours or less leave the cause of early labor untouched. Restorative reproductive medicine asks why labor started early, which directs attention to evaluation before pregnancy and in its early weeks. The authors report that calcium channel blockers and beta-adrenergic receptor agonists did not prolong gestation beyond 48 hours.
Our editorial summary of this paper, not the article's abstract.
Abstract
Objective
Our aim was to determine the efficacy and safety of tocolytic agents currently used to treat premature labor.
Study Design
We carried out a comprehensive review of tocolytic agents in the treatment of premature labor. Three hundred twenty-eight studies published between 1933 and 1992 were analyzed.
Results
An analysis of randomized, placebo-controlled, clinical trials showed that magnesium sulfate is not better than placebo in the treatment of premature labor. beta-Adrenergic receptor agonists effectively stop premature labor for only 24 to 48 hours. Calcium channel blockers and oxytocin antagonists inhibit uterine contractions, but their role in stopping labor is undefined. Prostaglandin inhibitors appear to be effective in treating premature labor and have few adverse side effects.
Conclusions
The only tocolytic drugs that might be effective are the prostaglandin inhibitors. Tocolytic agents should be used only between 24 and 32 completed weeks of gestation. Magnesium sulfate should not be used to treat premature labor. Oxytocin antagonists should be used only in experimental clinical trials. Calcium channel blockers and beta-adrenergic receptor agonists inhibit uterine contractions but do not prolong gestation for longer than 48 hours.